Race Oncology

Race Oncology is a company listed under the stock ticker RAC (AU).

View the org chart displaying its 8 main executives

Most searched biographies at Race Oncology

• Daniel Tillett, Chief Executive Officer
• Phillip Lynch, Non-Executive Director
• Mary Harney, Non-Executive Chairman of the Board

Popular executive movements at Race Oncology

• Brendan Brown will join the company as Chief Financial Officer on Apr. 1, 2024  (posted on March 18 2024).

Create your alert
to follow the executive moves at Race Oncology.

Race Oncology has 2,289 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Delphia Therapeutics has just announced a $67 Million fundraising (posted on May 7 2024).
• Karius has just announced a $100 Million fundraising (posted on May 3 2024).
• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Race Oncology

• News – Race Oncology

Social media about Race Oncology

• Race Oncology on Wikipedia, Google News & Yahoo Finance
• Race Oncology on LinkedIn, Twitter & YouTube

Contact by email its executives including Daniel Tillett

Call Race Oncology at +61 28...

View the org chart

Register to receive your alert

Report an error